Search results (193)
Article
Comprehensive coverage for building families
A comprehensive fertility benefit goes beyond a limited fertility benefit in terms of costs, outcomes, and employee happiness.
Read More
Article
Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read More
Article
What to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read More